Table 1 The relationship between the expression of circPRKCI and various clinicopathological variables in BC patients.

From: EIF4A3-mediated circPRKCI expression promotes triple-negative breast cancer progression by regulating WBP2 and PI3K/AKT signaling pathway

Patients Characteristics

Total

circPRKCI expression

P value

(n = 48)

High (n = 30)

Low (n = 18)

Age

   

0.8229

 <60

23

14

9

 

 ≥60

25

16

9

 

TNM stage

   

0.0352*

 I and II

37

20

17

 

 III and IV

11

10

1

 

Tumor size(cm)

   

<0.0001****

 ≤2

22

7

15

 

 >2

26

23

3

 

Lymph node metastasis

   

0.0158*

 Negative

29

14

15

 

 Positive

19

16

3

 

Recurrence and metastasis

   

0.2631

 No

46

28

18

 

 Yes

2

2

0

 
  1. *p < 0.05, ****p < 0.0001.
Back to article page